Gary S. Jacob's most recent trade in Hepion Pharmaceuticals Inc was a trade of 85,000 Stock Options done . Disclosure was reported to the exchange on Feb. 19, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Hepion Pharmaceuticals Inc | S. Gary Jacob | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2024 | 85,000 | 102,120 | - | - | Stock Options | |
| OKYO Pharma Limited - Ordi... | Gary S. Jacob | Chief Executive Officer and Director | Purchase of securities on an exchange or from another person at price $ 1.50 per share. | 15 Mar 2023 | 2,166,667 | 2,979,167 (0%) | 0% | 1.5 | 3,250,001 | Ords |
| OKYO Pharma Limited - Ordi... | Gary S. Jacob | Executive Director,Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.06 per share. | 19 May 2022 | 812,500 | 812,500 (0%) | 0% | 0.1 | 50,000 | Ords |
| OKYO Pharma Limited - Ordi... | Gary S. Jacob | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 19 May 2022 | 12,500 | 12,500 | - | 4 | 50,000 | American Depositary Shares |
| Virpax Pharmaceuticals Inc | Gary S. Jacob | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 12,091 | 12,091 | - | - | Stock Option (right to buy) | |
| Cardiff Oncology Inc | Gary S. Jacob | Former Director | Other type of transaction at price $ 0.00 per share. | 10 Jun 2021 | 44,734 | 76,106 | - | - | Stock Options | |
| Cardiff Oncology Inc | Gary S. Jacob | Former Director | Other type of transaction at price $ 0.00 per share. | 10 Jun 2021 | 28,858 | 76,106 | - | - | Stock Options | |
| Cardiff Oncology Inc | Gary S. Jacob | Former Director | Other type of transaction at price $ 0.00 per share. | 10 Jun 2021 | 755 | 76,106 | - | - | Stock Options | |
| Cardiff Oncology Inc | Gary S. Jacob | Former Director | Other type of transaction at price $ 0.00 per share. | 10 Jun 2021 | 530 | 76,106 | - | - | Stock Options | |
| Cardiff Oncology Inc | Gary S. Jacob | Former Director | Other type of transaction at price $ 0.00 per share. | 10 Jun 2021 | 293 | 76,106 | - | - | Stock Options | |
| Cardiff Oncology Inc | Gary S. Jacob | Former Director | Other type of transaction at price $ 0.00 per share. | 10 Jun 2021 | 223 | 76,106 | - | - | Stock Options | |
| Cardiff Oncology Inc | Gary S. Jacob | Former Director | Other type of transaction at price $ 0.00 per share. | 10 Jun 2021 | 223 | 76,106 | - | - | Stock Options | |
| Cardiff Oncology Inc | Gary S. Jacob | Former Director | Other type of transaction at price $ 0.00 per share. | 10 Jun 2021 | 218 | 76,106 | - | - | Stock Options | |
| Hepion Pharmaceuticals Inc | Gary S. Jacob | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 250,000 | 342,785 | - | - | Stock Options | |
| Virpax Pharmaceuticals Inc | Gary S. Jacob | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2021 | 13,183 | 13,183 | - | - | Stock Option (right to buy) | |
| Cardiff Oncology Inc | Gary S. Jacob | Director | Purchase of securities on an exchange or from another person at price $ 10.42 per share. | 23 Mar 2021 | 1,900 | 21,452 (0%) | 0% | 10.4 | 19,804 | Common Stock |
| Cardiff Oncology Inc | Gary S. Jacob | Director | Purchase of securities on an exchange or from another person at price $ 10.40 per share. | 23 Mar 2021 | 470 | 21,922 (0%) | 0% | 10.4 | 4,886 | Common Stock |
| Virpax Pharmaceuticals Inc | Gary S. Jacob | Director | Purchase of securities on an exchange or from another person at price $ 6.79 per share. | 17 Feb 2021 | 3,500 | 3,500 | - | 6.8 | 23,762 | Common Stock, $0.00001 par value |
| Hepion Pharmaceuticals Inc | Gary S. Jacob | Director | Purchase of securities on an exchange or from another person at price $ 1.66 per share. | 01 Dec 2020 | 12,000 | 12,059 (0%) | 0% | 1.7 | 19,920 | Common Stock |
| Hepion Pharmaceuticals Inc | Gary S. Jacob | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2020 | 30,000 | 92,785 | - | - | Stock Options |